Autoimmune Disease Diagnosis And Treatment
Expert-defined terms from the Professional Certificate in Autoimmune Disease Advocacy course at LearnUNI. Free to read, free to share, paired with a professional course.
ABAT – Antibody‑Based Assay Technology #
A laboratory method that detects specific autoantibodies in serum.
Example #
Using ABAT to identify anti‑CCP antibodies in suspected rheumatoid arthritis.
Practical application #
Enables rapid screening in primary care settings.
Challenges #
Variable sensitivity across laboratories; cost of reagents.
ACR Criteria – Classification standards set by the American College of Rh… #
ACR Criteria – Classification standards set by the American College of Rheumatology for specific autoimmune diseases.
Example #
Applying the 2010 ACR criteria for systemic lupus erythematosus.
Practical application #
Provides a uniform framework for research enrollment and clinical diagnosis.
Challenges #
Criteria may lag behind emerging biomarkers; some patients fall outside strict cut‑offs.
ACTH – Adrenocorticotropic hormone, a pituitary hormone that stimulates c… #
ACTH – Adrenocorticotropic hormone, a pituitary hormone that stimulates cortisol production.
Example #
Measuring ACTH levels to assess adrenal insufficiency in patients on long‑term steroids.
Practical application #
Guides tapering schedules for immunosuppressive therapy.
Challenges #
Stress‑induced fluctuations can confound interpretation.
Adjuvant Therapy – Additional treatment used to enhance the effectiveness… #
Adjuvant Therapy – Additional treatment used to enhance the effectiveness of a primary therapy.
Example #
Adding hydroxychloroquine as an adjuvant to methotrexate in lupus management.
Practical application #
Improves disease control while allowing lower doses of toxic drugs.
Challenges #
Increases risk of drug‑drug interactions; monitoring burden rises.
ANA – Antinuclear Antibody test, a screening assay for autoantibodies dir… #
ANA – Antinuclear Antibody test, a screening assay for autoantibodies directed against nuclear components.
Example #
A positive ANA at 1:160 with a speckled pattern in a patient with joint pain.
Practical application #
First‑line test in evaluating suspected systemic autoimmune disease.
Challenges #
Low specificity; false‑positive results common in healthy individuals and infections.
Anti‑CCP – Anticyclic Citrullinated Peptide antibody, highly specific for… #
Anti‑CCP – Anticyclic Citrullinated Peptide antibody, highly specific for rheumatoid arthritis.
Example #
Detecting anti‑CCP in a 45‑year‑old female with early morning stiffness.
Practical application #
Predicts erosive disease and informs early aggressive therapy.
Challenges #
Not all RA patients are anti‑CCP positive; assay variability between kits.
Anti‑dsDNA – Antibody against double‑stranded DNA, a hallmark of systemic… #
Anti‑dsDNA – Antibody against double‑stranded DNA, a hallmark of systemic lupus erythematosus.
Example #
Rising anti‑dsDNA titers correlate with flare of nephritis.
Practical application #
Used to monitor disease activity and guide immunosuppressive dosing.
Challenges #
Titers can fluctuate independent of clinical status; assay standardization needed.
Anti‑ENA – Antibody panel targeting Extractable Nuclear Antigens such as… #
Anti‑ENA – Antibody panel targeting Extractable Nuclear Antigens such as Ro, La, Sm, and RNP.
Example #
Positive anti‑Ro/SSA indicating possible Sjögren’s involvement.
Practical application #
Helps differentiate overlapping autoimmune syndromes.
Challenges #
Limited sensitivity; interpretation requires clinical correlation.
APC – Antigen‑Presenting Cell, a cell type that processes and presents an… #
APC – Antigen‑Presenting Cell, a cell type that processes and presents antigens to T‑cells.
Example #
Dendritic cells presenting myelin basic protein in multiple sclerosis.
Practical application #
Target for tolerogenic vaccines aimed at resetting immune tolerance.
Challenges #
Modulating APC function without compromising host defense is complex.
Arthrocentesis – Needle aspiration of synovial fluid from a joint for dia… #
Arthrocentesis – Needle aspiration of synovial fluid from a joint for diagnostic analysis.
Example #
Obtaining fluid from a swollen knee to rule out septic arthritis.
Practical application #
Distinguishes inflammatory from infectious processes, guiding therapy.
Challenges #
Procedure discomfort; low yield in early disease; risk of iatrogenic infection.
Autoimmune Panel – A grouped set of serologic tests that screen for multi… #
Autoimmune Panel – A grouped set of serologic tests that screen for multiple autoantibodies simultaneously.
Example #
Ordering an autoimmune panel that includes ANA, anti‑CCP, anti‑ENA, and rheumatoid factor.
Practical application #
Efficient initial screening when clinical picture is ambiguous.
Challenges #
Increased false‑positive rate; insurance coverage may be limited.
Autoimmunity – The immune system’s aberrant response against self‑antigen… #
Autoimmunity – The immune system’s aberrant response against self‑antigens, leading to tissue damage.
Example #
Breakdown of central tolerance resulting in type 1 diabetes.
Practical application #
Conceptual framework for developing tolerance‑inducing therapies.
Challenges #
Multifactorial etiology makes pinpointing triggers difficult.
Autoantibody – Antibody produced by the host that targets its own protein… #
Autoantibody – Antibody produced by the host that targets its own proteins, lipids, or nucleic acids.
Example #
Anti‑myelin antibodies in neuromyelitis optica.
Practical application #
Serves as a diagnostic biomarker and sometimes a pathogenic driver.
Challenges #
Not all autoantibodies are disease‑causing; distinguishing pathogenic from epiphenomenal is essential.
Baseline Assessment – Initial comprehensive evaluation of disease status… #
Baseline Assessment – Initial comprehensive evaluation of disease status before starting therapy.
Example #
Recording DAS28, renal function, and patient‑reported outcomes before initiating biologic treatment.
Practical application #
Establishes reference point for monitoring treatment response.
Challenges #
Time‑consuming; variability in measurement tools across clinics.
Biomarker – Measurable indicator of a biological state, often used for di… #
Biomarker – Measurable indicator of a biological state, often used for diagnosis, prognosis, or therapeutic monitoring.
Example #
Serum ferritin as a biomarker of disease activity in adult‑onset Still’s disease.
Practical application #
Guides personalized treatment decisions and tracks disease trajectory.
Challenges #
Validation across diverse populations; assay standardization.
Biopsy – Tissue sampling for histopathologic examination, frequently empl… #
Biopsy – Tissue sampling for histopathologic examination, frequently employed to confirm organ involvement.
Example #
Skin punch biopsy revealing interface dermatitis in cutaneous lupus.
Practical application #
Provides definitive diagnosis when serology is inconclusive.
Challenges #
Invasive; may yield non‑representative tissue; interpretation requires specialist expertise.
Bone Marrow Aspirate – Collection of marrow cells for evaluation of hemat… #
Bone Marrow Aspirate – Collection of marrow cells for evaluation of hematologic abnormalities associated with autoimmune disease.
Example #
Assessing marrow for aplastic anemia in systemic lupus erythematosus.
Practical application #
Determines whether cytopenias are immune‑mediated or marrow‑intrinsic.
Challenges #
Procedural discomfort; risk of infection; limited availability in outpatient settings.
Bronchoscopy – Endoscopic examination of the airways, often used to obtai… #
Bronchoscopy – Endoscopic examination of the airways, often used to obtain samples in pulmonary autoimmune disease.
Example #
Performing bronchoscopy with BAL to detect alveolar hemorrhage in microscopic polyangiitis.
Practical application #
Provides diagnostic material and helps assess disease severity.
Challenges #
Requires sedation; potential for hypoxemia; interpretation of lavage fluid is nuanced.
CAP – Complete Autoimmune Profile, a comprehensive serologic work‑up that… #
CAP – Complete Autoimmune Profile, a comprehensive serologic work‑up that includes ANA, ENA, RF, anti‑CCP, and complement levels.
Example #
Ordering a CAP for a patient with unexplained arthralgia and rash.
Practical application #
Streamlines ordering process and reduces duplicate testing.
Challenges #
High cost; potential for incidental findings leading to unnecessary work‑up.
Case‑Control Study – Observational research design comparing individuals… #
Case‑Control Study – Observational research design comparing individuals with a disease (cases) to those without (controls) to identify risk factors.
Example #
Investigating the association between smoking and rheumatoid arthritis using a case‑control design.
Practical application #
Generates hypotheses for preventive strategies.
Challenges #
Susceptible to recall bias; control selection must be meticulous.
Cellular Immunotherapy – Treatment that utilizes modified immune cells, s… #
Cellular Immunotherapy – Treatment that utilizes modified immune cells, such as CAR‑T cells, to target autoimmune pathology.
Example #
Investigating regulatory T‑cell expansion to suppress autoimmune inflammation.
Practical application #
Offers potential for disease‑specific immune re‑education.
Challenges #
Manufacturing complexity; risk of off‑target effects; high cost.
Cytokine Storm – Exaggerated release of pro‑inflammatory cytokines that c… #
Cytokine Storm – Exaggerated release of pro‑inflammatory cytokines that can exacerbate autoimmune disease flares.
Example #
Severe systemic lupus flare accompanied by elevated IL‑6 and ferritin.
Practical application #
Identifies patients who may benefit from cytokine‑targeted biologics.
Challenges #
Distinguishing cytokine storm from infection‑related cytokinemia; rapid intervention required.
Cytokine Profile – Pattern of cytokine concentrations measured in serum o… #
Cytokine Profile – Pattern of cytokine concentrations measured in serum or tissue, reflecting immune activation status.
Example #
High IL‑17 and IL‑23 levels indicating a Th17‑dominant pathology in psoriatic arthritis.
Practical application #
Helps select appropriate biologic agents (e.g., IL‑17 inhibitors).
Challenges #
Variability due to circadian rhythm, sample handling, and assay platform.
DCCT – Diabetes Control and Complications Trial, a landmark study that in… #
DCCT – Diabetes Control and Complications Trial, a landmark study that informs immunomodulatory approaches in type 1 diabetes.
Example #
Applying lessons from DCCT to design tolerance‑inducing vaccines for autoimmune diabetes.
Practical application #
Provides evidence for early intensive therapy to prevent complications.
Challenges #
Translating findings to broader autoimmune contexts requires adaptation.
Diagnostic Delay – The interval between symptom onset and definitive diag… #
Diagnostic Delay – The interval between symptom onset and definitive diagnosis, often prolonged in autoimmune conditions.
Example #
Average diagnostic delay of 3 years in systemic sclerosis.
Practical application #
Highlights need for education and streamlined referral pathways.
Challenges #
Nonspecific symptoms; limited access to specialty testing.
Diagnostic Imaging – Use of radiologic modalities (X‑ray, MRI, ultrasound… #
Diagnostic Imaging – Use of radiologic modalities (X‑ray, MRI, ultrasound) to detect structural changes in autoimmune disease.
Example #
MRI showing synovitis and erosions in early rheumatoid arthritis.
Practical application #
Provides objective evidence of disease activity and guides treatment escalation.
Challenges #
Radiation exposure, cost, and operator dependence for ultrasound.
DMARD – Disease‑Modifying Anti‑Rheumatic Drug, a class of agents that alt… #
DMARD – Disease‑Modifying Anti‑Rheumatic Drug, a class of agents that alter disease course rather than merely relieve symptoms.
Example #
Initiating methotrexate as a first‑line DMARD in newly diagnosed RA.
Practical application #
Reduces joint damage and improves long‑term functional outcomes.
Challenges #
Monitoring for hepatotoxicity and bone marrow suppression; delayed onset of action.
EULAR – European League Against Rheumatism, an organization that publishe… #
EULAR – European League Against Rheumatism, an organization that publishes guidelines and classification criteria for autoimmune diseases.
Example #
Following the 2022 EULAR recommendations for the management of systemic lupus erythematosus.
Practical application #
Provides evidence‑based, internationally harmonized treatment pathways.
Challenges #
Guidelines may not account for regional drug availability or patient heterogeneity.
Exacerbation – A worsening or flare of disease activity after a period of… #
Exacerbation – A worsening or flare of disease activity after a period of stability.
Example #
Sudden increase in joint pain and swelling signaling an RA exacerbation.
Practical application #
Triggers reassessment of therapy intensity and possible addition of short‑term steroids.
Challenges #
Differentiating true flare from infection or medication side‑effects.
FAIR – Findable, Accessible, Interoperable, Reusable principles applied t… #
FAIR – Findable, Accessible, Interoperable, Reusable principles applied to data sharing in autoimmune research.
Example #
Publishing trial datasets in a FAIR‑compliant repository for secondary analysis.
Practical application #
Enhances collaboration and accelerates discovery of novel biomarkers.
Challenges #
Requires technical infrastructure and consistent metadata curation.
Ferritin – Acute‑phase protein often elevated in inflammatory states and… #
Ferritin – Acute‑phase protein often elevated in inflammatory states and used as a disease activity marker.
Example #
High serum ferritin correlating with disease activity in adult‑onset Still’s disease.
Practical application #
Assists in monitoring response to immunosuppressive therapy.
Challenges #
Elevated in infection, liver disease, and iron overload; specificity limited.
First‑Line Therapy – Initial treatment recommended by guidelines for a pa… #
First‑Line Therapy – Initial treatment recommended by guidelines for a particular disease state.
Example #
Starting low‑dose glucocorticoids plus methotrexate as first‑line for moderate RA.
Practical application #
Sets baseline for therapeutic response and safety monitoring.
Challenges #
Patient comorbidities may preclude standard first‑line agents.
Flarescore – Composite scoring system that quantifies disease flare sever… #
Flarescore – Composite scoring system that quantifies disease flare severity using clinical and laboratory parameters.
Example #
Using the Flarescore to decide whether to add a biologic during a lupus flare.
Practical application #
Standardizes decision‑making across providers and research studies.
Challenges #
Requires validation in diverse populations; may be cumbersome in busy clinics.
Genetic Susceptibility – Inherited variants that increase the likelihood… #
Genetic Susceptibility – Inherited variants that increase the likelihood of developing an autoimmune disease.
Example #
HLA‑DRB1*04 associated with increased risk for rheumatoid arthritis.
Practical application #
May inform risk stratification and early screening in families.
Challenges #
Polygenic nature limits predictive power; ethical concerns about genetic testing.
Glucocorticoid Pulse – High‑dose short‑term administration of steroids to… #
Glucocorticoid Pulse – High‑dose short‑term administration of steroids to rapidly control severe inflammation.
Example #
1 g methylprednisolone IV daily for three days to treat severe lupus nephritis.
Practical application #
Achieves swift disease suppression when oral regimens are insufficient.
Challenges #
Potential for acute side‑effects such as hypertension, hyperglycemia, and infection.
HLA Typing – Laboratory determination of human leukocyte antigen alleles,… #
HLA Typing – Laboratory determination of human leukocyte antigen alleles, useful for disease association and transplant compatibility.
Example #
Identifying HLA‑B27 positivity in a patient with suspected ankylosing spondylitis.
Practical application #
Supports diagnostic confidence and may predict disease phenotype.
Challenges #
High cost; limited utility in diseases without strong HLA linkage.
Histopathology – Microscopic examination of tissue to assess cellular arc… #
Histopathology – Microscopic examination of tissue to assess cellular architecture and inflammatory infiltrates.
Example #
Lymphocytic infiltration with germinal centers in salivary gland biopsy of Sjögren’s syndrome.
Practical application #
Confirms diagnosis when serology is equivocal.
Challenges #
Requires expert pathologists; sampling error may miss focal lesions.
IL‑6 Inhibitor – Biologic agent that blocks interleukin‑6 signaling, redu… #
IL‑6 Inhibitor – Biologic agent that blocks interleukin‑6 signaling, reducing inflammation.
Example #
Administering tocilizumab for refractory rheumatoid arthritis after DMARD failure.
Practical application #
Offers an alternative pathway when TNF inhibitors are ineffective.
Challenges #
Increased infection risk; monitoring of lipid profiles and liver enzymes required.
Imaging Biomarker – Radiologic feature that quantitatively reflects disea… #
Imaging Biomarker – Radiologic feature that quantitatively reflects disease activity or structural damage.
Example #
Power Doppler signal intensity correlating with synovitis severity in early RA.
Practical application #
Enables objective monitoring of therapeutic response.
Challenges #
Inter‑observer variability; need for standardized acquisition protocols.
Immunomodulator – Agent that modifies the immune response, either enhanci… #
Immunomodulator – Agent that modifies the immune response, either enhancing or suppressing activity.
Example #
Using azathioprine as an immunomodulator in inflammatory bowel disease associated with autoimmune colitis.
Practical application #
Balances disease control with preservation of host defense.
Challenges #
Dose‑dependent toxicity; requires regular laboratory surveillance.
Immunophenotyping – Flow cytometric analysis of cell surface markers to c… #
Immunophenotyping – Flow cytometric analysis of cell surface markers to characterize immune cell subsets.
Example #
Identifying an expanded CD4⁺CD25⁺FOXP3⁺ regulatory T‑cell population in a patient responding to tolerance therapy.
Practical application #
Guides personalized immunotherapy and monitors immune reconstitution.
Challenges #
Technical complexity; requires fresh samples and specialized equipment.
Inflammatory Index – Composite metric combining laboratory markers (CRP,… #
Inflammatory Index – Composite metric combining laboratory markers (CRP, ESR) and clinical findings to gauge inflammation.
Example #
Calculating the inflammatory index to decide on escalation of therapy in ulcerative colitis.
Practical application #
Provides a quick snapshot for outpatient decision‑making.
Challenges #
Acute infections can falsely elevate scores; may not reflect organ‑specific activity.
Interleukin‑17 (IL‑17) – Pro‑inflammatory cytokine produced by Th17 cells… #
Interleukin‑17 (IL‑17) – Pro‑inflammatory cytokine produced by Th17 cells, implicated in several autoimmune diseases.
Example #
Elevated IL‑17 levels in psoriatic arthritis correlating with skin and joint severity.
Practical application #
Targeted by agents such as secukinumab to reduce disease burden.
Challenges #
Blockade may increase susceptibility to fungal infections; long‑term safety data still evolving.
JAK Inhibitor – Small‑molecule drug that blocks Janus kinase pathways, at… #
JAK Inhibitor – Small‑molecule drug that blocks Janus kinase pathways, attenuating cytokine signaling.
Example #
Initiating tofacitinib for a patient with rheumatoid arthritis unresponsive to methotrexate.
Practical application #
Oral administration provides convenient alternative to injectable biologics.
Challenges #
Risks of thrombosis, lipid abnormalities, and opportunistic infections; requires periodic lab monitoring.
Kits (Diagnostic Kits) – Pre‑packaged sets of reagents and controls for p… #
Kits (Diagnostic Kits) – Pre‑packaged sets of reagents and controls for performing specific laboratory assays.
Example #
Using a commercial ANA kit with HEp‑2 cells for indirect immunofluorescence.
Practical application #
Standardizes testing across laboratories, reducing variability.
Challenges #
Batch‑to‑batch differences; sometimes limited sensitivity for low‑titer antibodies.
Lupus Anticoagulant – Autoantibody that interferes with phospholipid‑depe… #
Lupus Anticoagulant – Autoantibody that interferes with phospholipid‑dependent coagulation assays, associated with antiphospholipid syndrome.
Example #
Positive dilute Russell viper venom test indicating lupus anticoagulant presence.
Practical application #
Identifies patients at risk for thrombosis, guiding anticoagulation therapy.
Challenges #
Laboratory interference can lead to false‑positive results; requires confirmatory testing.
Macrophage Activation Syndrome (MAS) – Life‑threatening hyperinflammatory… #
Macrophage Activation Syndrome (MAS) – Life‑threatening hyperinflammatory condition characterized by excessive macrophage activation.
Example #
MAS occurring in a child with systemic juvenile idiopathic arthritis presenting with pancytopenia and high ferritin.
Practical application #
Prompt recognition leads to aggressive immunosuppression (e.g., etoposide, steroids).
Challenges #
Overlap with infection; rapid diagnostic algorithms are essential.
Magnetic Resonance Imaging (MRI) – Non‑invasive imaging technique providi… #
Magnetic Resonance Imaging (MRI) – Non‑invasive imaging technique providing high‑resolution soft‑tissue contrast, useful for detecting inflammation.
Example #
MRI of the sacroiliac joints revealing bone marrow edema in early ankylosing spondylitis.
Practical application #
Detects subclinical disease, influencing early therapeutic decisions.
Challenges #
Cost, limited availability, contraindications in patients with certain implants.
MEASURE – Acronym for “Monitoring Efficacy And Response Using Clinical En… #
MEASURE – Acronym for “Monitoring Efficacy And Response Using Clinical Endpoints,” a framework for assessing treatment outcomes.
Example #
Applying the MEASURE protocol to evaluate response to rituximab in vasculitis.
Practical application #
Standardizes data collection across clinical trials.
Challenges #
Requires training; may increase documentation burden.
Microarray – High‑throughput platform that assesses expression of thousan… #
Microarray – High‑throughput platform that assesses expression of thousands of genes or autoantibody specificities simultaneously.
Example #
Using a microarray to identify a distinct interferon signature in systemic lupus erythematosus.
Practical application #
Supports precision medicine by matching patients to targeted therapies.
Challenges #
Data analysis complexity; need for bioinformatics expertise.
Monoclonal Antibody – Laboratory‑produced antibody that targets a single… #
Monoclonal Antibody – Laboratory‑produced antibody that targets a single antigenic epitope, used therapeutically to modulate immune pathways.
Example #
Infliximab, a monoclonal antibody against tumor necrosis factor‑α, used in Crohn’s disease.
Practical application #
Provides highly specific disease control with predictable pharmacodynamics.
Challenges #
Immunogenicity leading to anti‑drug antibodies; high cost.
Multiple Sclerosis (MS) – Chronic autoimmune demyelinating disease of the… #
Multiple Sclerosis (MS) – Chronic autoimmune demyelinating disease of the central nervous system characterized by relapses and progressive disability.
Example #
Initiating natalizumab in a patient with high‑activity relapsing‑remitting MS.
Practical application #
Early aggressive treatment reduces long‑term disability.
Challenges #
Monitoring for progressive multifocal leukoencephalopathy; adherence to infusion schedule.
Neutrophil‑to‑Lymphocyte Ratio (NLR) – Inflammatory biomarker calculated… #
Neutrophil‑to‑Lymphocyte Ratio (NLR) – Inflammatory biomarker calculated from complete blood count, reflecting systemic immune activation.
Example #
Elevated NLR correlating with disease activity in systemic vasculitis.
Practical application #
Simple, inexpensive tool for routine monitoring.
Challenges #
Influenced by infections, stress, and medications; not disease‑specific.
Next‑Generation Sequencing (NGS) – Advanced DNA sequencing technology ena… #
Next‑Generation Sequencing (NGS) – Advanced DNA sequencing technology enabling comprehensive genetic analysis, including HLA typing and somatic mutation detection.
Example #
Applying NGS to identify rare variants associated with autoimmune hepatitis.
Practical application #
Facilitates discovery of novel therapeutic targets.
Challenges #
Data interpretation complexity; ethical considerations regarding incidental findings.
Oligoclonal Bands – Discrete bands of immunoglobulins seen on cerebrospin… #
Oligoclonal Bands – Discrete bands of immunoglobulins seen on cerebrospinal fluid electrophoresis, indicative of intrathecal antibody production.
Example #
Presence of oligoclonal bands supporting diagnosis of MS in a patient with optic neuritis.
Practical application #
Helps differentiate demyelinating disease from other neurologic conditions.
Challenges #
May appear in infections and other inflammatory states; not entirely specific.
Oral Tolerance – Induction of immune unresponsiveness to specific antigen… #
Oral Tolerance – Induction of immune unresponsiveness to specific antigens through oral administration, explored as a therapeutic strategy.
Example #
Clinical trials testing oral collagen peptides to reduce autoimmunity in rheumatoid arthritis.
Practical application #
Potentially safe, non‑invasive method to re‑educate the immune system.
Challenges #
Variable efficacy; need for optimal dosing and antigen selection.
Outcome Measure – Quantitative tool used to assess the impact of an inter… #
Outcome Measure – Quantitative tool used to assess the impact of an intervention on disease status or patient quality of life.
Example #
Using the Health Assessment Questionnaire (HAQ) to gauge functional improvement after biologic therapy.
Practical application #
Provides objective evidence for treatment effectiveness and reimbursement.
Challenges #
Requires validation in specific disease populations; patient literacy may affect responses.
p‑ANCA – Perinuclear anti‑neutrophil cytoplasmic antibody, commonly assoc… #
p‑ANCA – Perinuclear anti‑neutrophil cytoplasmic antibody, commonly associated with microscopic polyangiitis and ulcerative colitis.
Example #
Positive p‑ANCA in a patient presenting with renal involvement and pulmonary hemorrhage.
Practical application #
Supports diagnosis of ANCA‑associated vasculitis and guides immunosuppressive regimen.
Challenges #
Low specificity; can be present in infections and drug‑induced conditions.
Paraneoplastic Autoimmunity – Autoimmune phenomena triggered by an underl… #
Paraneoplastic Autoimmunity – Autoimmune phenomena triggered by an underlying malignancy, often presenting with neurologic or dermatologic manifestations.
Example #
Anti‑Hu antibodies indicating a possible small‑cell lung carcinoma in a patient with sensory neuropathy.
Practical application #
Prompt cancer detection and treatment can resolve autoimmune symptoms.
Challenges #
Rare; requires high clinical suspicion and extensive work‑up.
Patient‑Reported Outcome (PRO) – Direct report from the patient about the… #
Patient‑Reported Outcome (PRO) – Direct report from the patient about their health status, symptoms, and functional ability without clinician interpretation.
Example #
A PRO score indicating severe fatigue despite low laboratory disease activity in lupus.
Practical application #
Informs shared decision‑making and captures aspects not reflected in lab tests.
Challenges #
Subjectivity; cultural and language differences may affect scoring.
Pharmacogenomics – Study of how genetic variations influence drug respons… #
Pharmacogenomics – Study of how genetic variations influence drug response, used to personalize autoimmune disease therapy.
Example #
TPMT genotype testing before initiating azathioprine to avoid myelotoxicity.
Practical application #
Reduces adverse drug reactions and optimizes efficacy.
Challenges #
Limited availability of rapid testing; interpretation of rare variants.
Plasma Exchange (PLEX) – Therapeutic removal of plasma components, includ… #
Plasma Exchange (PLEX) – Therapeutic removal of plasma components, including pathogenic autoantibodies, followed by replacement with donor plasma or albumin.
Example #
Performing PLEX in severe anti‑GBM disease to rapidly reduce circulating antibodies.
Practical application #
Provides rapid disease control when conventional immunosuppression is insufficient.
Challenges #
Requires vascular access; potential for hemodynamic instability and infection.
Polymyositis – Inflammatory myopathy characterized by symmetric proximal… #
Polymyositis – Inflammatory myopathy characterized by symmetric proximal muscle weakness and elevated muscle enzymes.
Example #
Treating polymyositis with high‑dose steroids followed by methotrexate maintenance.
Practical application #
Early recognition prevents irreversible muscle damage.
Challenges #
Overlap with inclusion body myositis; steroid side‑effects limit long‑term use.
Positron Emission Tomography (PET) – Imaging modality that visualizes met… #
Positron Emission Tomography (PET) – Imaging modality that visualizes metabolic activity using radiotracers, useful in detecting inflammatory lesions.
Example #
FDG‑PET revealing active vasculitis in large vessels not seen on MRI.
Practical application #
Guides biopsy site selection and monitors treatment response.
Challenges #
Radiation exposure; limited specificity for inflammation versus infection.
Predictive Biomarker – Biological marker that forecasts therapeutic respo… #
Predictive Biomarker – Biological marker that forecasts therapeutic response or disease progression before treatment initiation.
Example #
High baseline interferon‑signature predicting favorable response to anti‑IFN‑α therapy in lupus.
Practical application #
Enables tailored treatment plans, avoiding ineffective therapies.
Challenges #
Validation across cohorts; may require invasive sampling.
Pro‑inflammatory Cytokine – Signaling molecule that promotes inflammation… #
Pro‑inflammatory Cytokine – Signaling molecule that promotes inflammation, such as TNF‑α, IL‑1β, or IL‑6.
Example #
Elevated TNF‑α levels driving joint destruction in rheumatoid arthritis.
Practical application #
Basis for developing cytokine‑targeted biologic agents.
Challenges #
Redundancy in cytokine networks can diminish single‑target efficacy.
Proteinuria – Presence of excess protein in urine, indicating renal invol… #
Proteinuria – Presence of excess protein in urine, indicating renal involvement in autoimmune diseases.
Example #
New‑onset proteinuria prompting renal biopsy in systemic lupus erythematosus.
Practical application #
Serves as a key marker for assessing renal disease activity and treatment response.
Challenges #
Non‑specific; can be affected by hypertension, diabetes, or infection.
Psoriatic Arthritis (PsA) – Inflammatory arthritis associated with psoria… #
Psoriatic Arthritis (PsA) – Inflammatory arthritis associated with psoriasis, featuring joint pain, enthesitis, and skin lesions.
Example #
Initiating secukinumab for a patient with severe PsA refractory to NSAIDs.
Practical application #
Early biologic therapy can prevent joint erosions and improve quality of life.
Challenges #
Co‑existing skin disease may require combination therapy; monitoring for infection remains essential.
Radiographic Progression – Worsening of structural damage visible on imag… #
Radiographic Progression – Worsening of structural damage visible on imaging over time, indicating ongoing disease activity.
Example #
Increased Sharp score after 12 months of untreated rheumatoid arthritis.
Practical application #
Objective measure to assess long‑term effectiveness of disease‑modifying agents.
Challenges #
Imaging frequency limited by radiation exposure and cost; inter‑reader variability.
Randomized Controlled Trial (RCT) – Gold‑standard study design that rando… #
Randomized Controlled Trial (RCT) – Gold‑standard study design that randomly assigns participants to intervention or control groups to evaluate efficacy.
Example #
RCT demonstrating superiority of belimumab over placebo in systemic lupus erythematosus.
Practical application #
Provides high‑quality evidence to inform clinical guidelines.
Challenges #
Recruitment difficulties in rare autoimmune diseases; ethical concerns with placebo use.
Refractory Disease – Condition that fails to achieve adequate control des… #
Refractory Disease – Condition that fails to achieve adequate control despite optimal standard therapy.
Example #
Refractory ulcerative colitis requiring salvage therapy with cyclosporine.
Practical application #
Triggers consideration of alternative mechanisms, such as JAK inhibition or stem‑cell transplantation.
Challenges #
Higher risk of adverse events; limited evidence for off‑label options.
Regulatory T‑Cell (Treg) – Subset of CD4⁺ T‑cells expressing FOXP3 that s… #
Regulatory T‑Cell (Treg) – Subset of CD4⁺ T‑cells expressing FOXP3 that suppress immune responses and maintain self‑tolerance.
Example #
Reduced Treg frequency correlating with disease activity in multiple sclerosis.
Practical application #
Therapeutic expansion of Tregs is being explored to restore tolerance in autoimmunity.
Challenges #
Ensuring antigen specificity; risk of global immunosuppression.
Remission – State of minimal or absent disease activity, often defined by… #
Remission – State of minimal or absent disease activity, often defined by composite indices and absence of glucocorticoid use.
Example #
Achieving DAS28 < 2.6 for six consecutive months in rheumatoid arthritis.
Practical application #
Goal of most treatment strategies; guides tapering of therapy.
Challenges #
Defining remission uniformly across diseases; subclinical activity may persist.
Reproductive Toxicity – Potential adverse effects of a medication on fert… #
Reproductive Toxicity – Potential adverse effects of a medication on fertility, pregnancy, or fetal development.
Example #
Methotrexate is contraindicated during pregnancy due to teratogenic risk.
Practical application #
Requires pre‑conception counseling and appropriate drug substitution.
Challenges #
Limited data on newer agents; balancing disease control with reproductive safety.
Risk Stratification – Process of categorizing patients based on likelihoo… #
Risk Stratification – Process of categorizing patients based on likelihood of disease progression or complications.
Example #
Using the SLEDAI score to identify high‑risk patients for organ damage.
Practical application #
Informs intensity of monitoring and therapeutic aggressiveness.
Challenges #
Requires validated tools; may oversimplify complex disease trajectories.
Rituximab – Chimeric monoclonal antibody targeting CD20 on B‑cells, leadi… #
Rituximab – Chimeric monoclonal antibody targeting CD20 on B‑cells, leading to depletion of circulating B‑cell populations.
Example #
Administering rituximab for refractory rheumatoid arthritis after failure of TNF inhibitors.
Practical application #
Effective in several antibody‑mediated diseases, including ANCA‑associated vasculitis.
Challenges #
Infusion reactions; prolonged B‑cell depletion increases infection risk; monitoring of immunoglobulin levels required.
Seronegative Arthritis – Arthritis lacking typical autoantibodies such as… #
Seronegative Arthritis – Arthritis lacking typical autoantibodies such as rheumatoid factor or anti‑CCP.
Example #
Patient with axial involvement and HLA‑B27 positivity but negative RF.
Practical application #
Guides selection of imaging and therapeutic options distinct from seropositive disease.
Challenges #
Diagnostic uncertainty; may delay appropriate treatment.
Serology – Laboratory analysis of blood serum to detect antibodies, antig… #
Serology – Laboratory analysis of blood serum to detect antibodies, antigens, or other biomarkers.
Example #
Positive anti‑ENA panel confirming mixed connective tissue disease.
Practical application #
Central component of autoimmune diagnostic algorithms.
Challenges #
Cross‑reactivity; need for confirmatory testing; variability in assay sensitivity.
SHR (Standardized Health Ratio) – Metric comparing observed health outcom… #
SHR (Standardized Health Ratio) – Metric comparing observed health outcomes to expected outcomes in a reference population.
Example #
Calculating SHR for infection rates in patients receiving high‑dose steroids.
Practical application #
Assesses safety profile of immunosuppressive regimens.
Challenges #
Requires robust reference data; may be confounded by comorbidities.
Skin Biopsy – Sampling of cutaneous tissue for histologic evaluation, oft… #
Skin Biopsy – Sampling of cutaneous tissue for histologic evaluation, often employed in dermatologic manifestations of autoimmunity.
Example: #
Example: